MENU
KYTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Kyverna Therapeutics (KYTX) Earnings Date & Reports
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
A.I. Advisor
published Earnings
KYTX is expected to report earnings to rise 7.94% to -68 cents per share on November 11
Q3'26
Est.
$-0.68
Q2'26
Beat
by $0.45
Q1'26
Beat
by $0.38
Q4'25
Beat
by $0.21
Q3'25
Beat
by $0.17
The last earnings report on August 11 showed earnings per share of -62 cents, beating the estimate of -108 cents. With 152.35K shares outstanding, the current market capitalization sits at 361.17M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
5980 Horton Street
Phone
+1 510 925-2492
Employees
130
Web
https://www.kyvernatx.com